NPI: 1508841990 · RENO, NV 89502 · Clinical Medical Laboratory · NPI assigned 12/08/2005
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 12/08/2005 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 744 | $9K |
| 2019 | 573 | $3K |
| 2020 | 2,974 | $272K |
| 2021 | 1,913 | $125K |
| 2022 | 1,279 | $86K |
| 2023 | 701 | $23K |
| 2024 | 142 | $281.09 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,806 | 4,521 | $421K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 643 | 637 | $70K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 204 | 202 | $13K |
| 86769 | 82 | 81 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,429 | 1,196 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 90 | 84 | $2K |
| 80053 | Comprehensive metabolic panel | 378 | 302 | $2K |
| 87529 | 12 | 12 | $737.52 | |
| 85610 | 581 | 405 | $729.20 | |
| 83992 | 12 | 12 | $187.20 | |
| 85730 | 14 | 13 | $36.22 | |
| 82247 | 24 | 13 | $23.02 | |
| 82248 | 23 | 13 | $23.02 | |
| 36415 | Collection of venous blood by venipuncture | 28 | 25 | $10.82 |